`
`Paper No. ______
`
`
`
`
`By: Eric W. Dittmann (DrReddysHelsinnIPR@paulhastings.com)
`
`Naveen Modi (DrReddysHelsinnIPR@paulhastings.com)
`
`Thomas L. Irving (tom.irving@finnegan.com)
`
`Mark E. Waddell (mwaddell@loeb.com)
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`DR. REDDY’S LABORATORIES, LTD., and
`DR. REDDY’S LABORATORIES, INC.
`Petitioner
`
`v.
`
`HELSINN HEALTHCARE S.A. and
`ROCHE PALO ALTO LLC,
`Patent Owners
`
`
`
`
`
`
`
`
`Case IPR2015-01550
`Patent 8,729,094
`
`
`
`
`
`
`
`
`PATENT OWNERS’ MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`Patent No. 8,729,094
`
`Helsinn Healthcare S.A. (“Helsinn”) and Roche Palo Alto LLC (“Roche”)
`
`(collectively, “Patent Owners”), submit the following mandatory notices in
`
`connection with the above-identified proceeding.1
`
`I.
`
`
`Real Party-in-Interest
`
`Pursuant to 37 C.F.R. § 42.8(b)(1), the real parties-in-interest are Helsinn
`
`and Roche, the assignees of record for U.S. Patent No. 8,729,094 (“the ’094
`
`patent”).
`
`II. Related Matters
`Patent Owners identify the following matters that may be deemed related
`
`pursuant to 37 C.F.R. § 42.8(b)(2).
`
`Proceedings before the USPTO Involving the Patent-at-Issue
`
`A.
`The ’094 patent, which is the subject of this proceeding, is at issue in the
`
`following inter partes review proceedings:
`
` Case IPR2015-01551
`
` Case IPR2015-01553
`
` Case IPR2015-01554
`
`
`1 Power of Attorneys appointing lead and back-up counsel for Helsinn and
`
`Roche are being filed concurrently with these Notices.
`
`1
`
`
`
`
`
`Patent No. 8,729,094
`
`Litigations Involving the Patent-at-Issue and/or Related Patents
`
`B.
`The ’094 patent or patents claiming their earliest priority date to the same
`
`provisional application No. 60/444,351, as the ’094 patent, are at issue in one or
`
`more of the following cases:
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Laboratories, Ltd. et al.,
`
`Civil Action Nos. 11-3962, 11-5579, 13-5815 (consolidated) (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Laboratories, Ltd. et al.,
`
`Civil Action Nos. 14-4274, 14-6341 (consolidated) (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Dr. Reddy’s Laboratories, Ltd. et al.,
`
`Civil Action No. 12-2867 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Aurobindo Pharma Ltd. et al.,
`
`Civil Action Nos. 13-688, 13-1612, 13-2101, 14-427, 14-709
`
`(consolidated) (D. Del.)
`
` Helsinn Healthcare S.A. et al. v. Gavis Pharma LLC,
`
`Civil Action No. 15-1228 (D.N.J.)
`
` Helsinn Healthcare S.A. et al. v. Par Pharmaceutical Inc. et al.,
`
`Civil Action No. 15-2078 (D.N.J)
`
` Helsinn Healthcare S.A. et al. v. Par Pharmaceutical Inc. et al.,
`
`Civil Action No. 15-265 (D. Del.)
`
`2
`
`
`
`Patent No. 8,729,094
`
`
` Helsinn Healthcare S.A. et al. v. Hospira, Inc. et al.,
`
`Civil Action No. 15-2077 (D.N.J)
`
` Helsinn Healthcare S.A. et al. v. Hospira, Inc. et al.,
`
`Civil Action No. 15-264 (D. Del)
`
`III. Lead and Back-Up Counsel and Service Information
`In accordance with 37 C.F.R. §42.8(b)(3) and (b)(4), Patent Owners identify
`
`the following lead and back-up counsel and service information:
`
`Lead Counsel
`
`Back-Up Counsel
`
`Eric W. Dittmann (Reg. No. 51,188)
`Paul Hastings LLP
`75 East 55th Street
`New York, NY 10022
`Telephone: (212) 318-6000
`Facsimile: (202) 319-4090
`Email: DrReddysHelsinnIPR
`@paulhastings.com
`
`Naveen Modi (Reg. No. 46,224)
`Paul Hastings LLP
`875 15th Street NW
`Washington, DC 20005
`Telephone: (202) 551-1990
`Facsimile: (202) 551-0490
`Email: DrReddysHelsinnIPR
`@paulhastings.com
`
`Back-Up Counsel
`
`Back-Up Counsel
`
`Thomas L. Irving (Reg. No. 28,619)
`Finnegan LLP
`901 New York Ave., NW
`Washington, DC 20001-4413
`Telephone: (202) 408-4082
`Facsimile: (202) 408-4400
`Email: tom.irving@finnegan.com
`
`Mark E. Waddell (Reg. No. 31,803)
`Loeb & Loeb LLP
`345 Park Avenue
`New York, NY 10154
`Telephone: (212) 407-4127
`Facsimile: (646) 619-4540
`Email: mwaddell@loeb.com
`
`3
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`Patent No. 8,729,094
`
`
`Dated: July 24, 2015
`
`By:
`
`
`/Eric W. Dittmann/
`Eric W. Dittmann (Reg. No. 51,188)
`Naveen Modi (Reg. No. 46,224)
`Thomas L. Irving (Reg. No. 28,619)
`Mark E. Waddell (Reg. No. 31,803)
`Counsel for Patent Owners
`
`4
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on July 24, 2015, a copy of the foregoing Patent
`
`Owners’ Mandatory Notices Pursuant to 37 C.F.R. § 42.8 was served by e-mail
`
`on the following counsel of record for Dr. Reddy’s Laboratories, Ltd. and Dr.
`
`Reddy’s Laboratories, Inc.:
`
`Michael H. Teschner (MTeschner.ipr@ldlkm.com)
`William L. Mentlik (WMentlik.ipr@ldlkm.com)
`Thomas M. Palisi (TPalisi.ipr@ldlkm.com)
`Maegan A. Fuller (MFuller.ipr@ldlkm.com)
`
`By:
`
`/Naveen Modi/
`Naveen Modi (Reg. No. 46,224)
`
`Counsel for Patent Owners
`
`
`
`
`
`
`
`Dated: July 24, 2015